Cargando…

Inhibitor of DNA binding in heart development and cardiovascular diseases

Id proteins, inhibitors of DNA binding, are transcription regulators containing a highly conserved helix-loop-helix domain. During multiple stages of normal cardiogenesis, Id proteins play major roles in early development and participate in the differentiation and proliferation of cardiac progenitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Wenyu, Xin, Yanguo, Hu, Jian, Sun, Yingxian, Zhao, Yinan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534900/
https://www.ncbi.nlm.nih.gov/pubmed/31126344
http://dx.doi.org/10.1186/s12964-019-0365-z
_version_ 1783421505336508416
author Hu, Wenyu
Xin, Yanguo
Hu, Jian
Sun, Yingxian
Zhao, Yinan
author_facet Hu, Wenyu
Xin, Yanguo
Hu, Jian
Sun, Yingxian
Zhao, Yinan
author_sort Hu, Wenyu
collection PubMed
description Id proteins, inhibitors of DNA binding, are transcription regulators containing a highly conserved helix-loop-helix domain. During multiple stages of normal cardiogenesis, Id proteins play major roles in early development and participate in the differentiation and proliferation of cardiac progenitor cells and mature cardiomyocytes. The fact that a depletion of Ids can cause a variety of defects in cardiac structure and conduction function is further evidence of their involvement in heart development. Multiple signalling pathways and growth factors are involved in the regulation of Ids in a cell- and tissue- specific manner to affect heart development. Recent studies have demonstrated that Ids are related to multiple aspects of cardiovascular diseases, including congenital structural, coronary heart disease, and arrhythmia. Although a growing body of research has elucidated the important role of Ids, no comprehensive review has previously compiled these scattered findings. Here, we introduce and summarize the roles of Id proteins in heart development, with the hope that this overview of key findings might shed light on the molecular basis of consequential cardiovascular diseases. Furthermore, we described the future prospective researches needed to enable advancement in the maintainance of the proliferative capacity of cardiomyocytes. Additionally, research focusing on increasing embryonic stem cell culture adaptability will help to improve the future therapeutic application of cardiac regeneration.
format Online
Article
Text
id pubmed-6534900
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65349002019-05-30 Inhibitor of DNA binding in heart development and cardiovascular diseases Hu, Wenyu Xin, Yanguo Hu, Jian Sun, Yingxian Zhao, Yinan Cell Commun Signal Review Id proteins, inhibitors of DNA binding, are transcription regulators containing a highly conserved helix-loop-helix domain. During multiple stages of normal cardiogenesis, Id proteins play major roles in early development and participate in the differentiation and proliferation of cardiac progenitor cells and mature cardiomyocytes. The fact that a depletion of Ids can cause a variety of defects in cardiac structure and conduction function is further evidence of their involvement in heart development. Multiple signalling pathways and growth factors are involved in the regulation of Ids in a cell- and tissue- specific manner to affect heart development. Recent studies have demonstrated that Ids are related to multiple aspects of cardiovascular diseases, including congenital structural, coronary heart disease, and arrhythmia. Although a growing body of research has elucidated the important role of Ids, no comprehensive review has previously compiled these scattered findings. Here, we introduce and summarize the roles of Id proteins in heart development, with the hope that this overview of key findings might shed light on the molecular basis of consequential cardiovascular diseases. Furthermore, we described the future prospective researches needed to enable advancement in the maintainance of the proliferative capacity of cardiomyocytes. Additionally, research focusing on increasing embryonic stem cell culture adaptability will help to improve the future therapeutic application of cardiac regeneration. BioMed Central 2019-05-24 /pmc/articles/PMC6534900/ /pubmed/31126344 http://dx.doi.org/10.1186/s12964-019-0365-z Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Hu, Wenyu
Xin, Yanguo
Hu, Jian
Sun, Yingxian
Zhao, Yinan
Inhibitor of DNA binding in heart development and cardiovascular diseases
title Inhibitor of DNA binding in heart development and cardiovascular diseases
title_full Inhibitor of DNA binding in heart development and cardiovascular diseases
title_fullStr Inhibitor of DNA binding in heart development and cardiovascular diseases
title_full_unstemmed Inhibitor of DNA binding in heart development and cardiovascular diseases
title_short Inhibitor of DNA binding in heart development and cardiovascular diseases
title_sort inhibitor of dna binding in heart development and cardiovascular diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534900/
https://www.ncbi.nlm.nih.gov/pubmed/31126344
http://dx.doi.org/10.1186/s12964-019-0365-z
work_keys_str_mv AT huwenyu inhibitorofdnabindinginheartdevelopmentandcardiovasculardiseases
AT xinyanguo inhibitorofdnabindinginheartdevelopmentandcardiovasculardiseases
AT hujian inhibitorofdnabindinginheartdevelopmentandcardiovasculardiseases
AT sunyingxian inhibitorofdnabindinginheartdevelopmentandcardiovasculardiseases
AT zhaoyinan inhibitorofdnabindinginheartdevelopmentandcardiovasculardiseases